The increased expression of PPAR-β/δ mRNA in colon cancers has been attributed to APC-β-catenin-TCF4-mediated transcription, similar to the well-known target gene β-catenin-TCF4 CCND1, which encodes cyclin D1. The gene discussed is CCND1; the disease is colonic neoplasm.